Nabilone for Non-motor Symptoms in Parkinson's Disease
NCT03773796
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Nabilone 0.25 mg
Sponsor
Medical University Innsbruck